<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03977337</url>
  </required_header>
  <id_info>
    <org_study_id>PROMIES</org_study_id>
    <nct_id>NCT03977337</nct_id>
  </id_info>
  <brief_title>Perioperative Pulmonary Monitoring in Major Emergency Surgery</brief_title>
  <acronym>PROMIES</acronym>
  <official_title>Perioperative Pulmonary Monitoring in Major Emergency Surgery -the PROMIES Project</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zealand University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zealand University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      1. Describe the incidence of postoperative hypoxemia after major emergency abdominal&#xD;
           surgery as well as correlate this to clinical outcomes.&#xD;
&#xD;
        2. Investigate the association between postoperative pulmonary complications and&#xD;
           respiratory muscle dysfunction.&#xD;
&#xD;
        3. Investigate the association between the length and type of incision as well as the&#xD;
           distance to the xiphoid process and respiratory muscle dysfunction.&#xD;
&#xD;
        4. Investigate the association between postoperative hypoxemia, myocardial ischemia and&#xD;
           ischemic electrocardiographic (ECG) changes within three days of major emergency&#xD;
           abdominal surgery&#xD;
&#xD;
        5. Describe the incidence of postoperative cardiac arrhythmias within three days of major&#xD;
           emergency abdominal surgery and the association with postoperative cardiovascular&#xD;
           complications within 30 days, 90 days and 1 year of surgery.&#xD;
&#xD;
        6. Describe the association between HRV and postoperative cardiovascular and&#xD;
           non-cardiovascular complications within 30 days, 90 days and 1 year of surgery&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">November 29, 2018</start_date>
  <completion_date type="Anticipated">November 30, 2019</completion_date>
  <primary_completion_date type="Anticipated">November 30, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change in postoperative maximal inspiratory mouth pressure from POD1 to POD3</measure>
    <time_frame>3 days</time_frame>
    <description>Maximal inspiratory mouth pressure [cmH2O] is measured on the first and third postoperative day to asses the change</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in postoperative maximal expiratory mouth pressure from POD1 to POD3</measure>
    <time_frame>3 days</time_frame>
    <description>Maximal expiratory mouth pressure [cmH2O] is measured on the first and third postoperative day to asses the change</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Length of surgical incision</measure>
    <time_frame>Day 1</time_frame>
    <description>The length of the surgical incision [cm] will be measured on the first postoperative day</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Heart Rate Variability (HRV)</measure>
    <time_frame>3 days</time_frame>
    <description>HRV assessed preoperatively - POD3, if this is not achievable then from POD0 - POD3</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The occurence of per- and postoperative cardiac arrhythmias (until POD3)</measure>
    <time_frame>3 days</time_frame>
    <description>The occurence of postoperative cardiac arrhythmia the first three days following surgery, with cardiac arrhythmia defined as:&#xD;
Atrial fibrillation (AF) or&#xD;
Atrial Flutter (AFL) or&#xD;
Ventricular Tachycardia (VT- both monomorphic and polymorphic types) or&#xD;
Recurrent sustained ventricular tachycardia (RSVT) or&#xD;
Ventricular fibrillation (VF) or&#xD;
Torsade de Pointes (TDP) or&#xD;
2nd degree atrioventricular (AV) block or&#xD;
3rd degree atrioventricular (AV) block</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The occurence of per- and postoperative ischemic ECG changes (until POD3)</measure>
    <time_frame>3 days</time_frame>
    <description>The occurence of per- and postoperative ischemic ECG changes the first three days following surgery, defined as:&#xD;
ST-depression ≥ 0,5 mm at the J-point in ≥ 2 contiguous leads or&#xD;
Inverted T waves ≥ 1 mm in ≥2 contiguous leads that have dominant R waves or&#xD;
ST-elevation ≥ 1 mm in ≥ 2 contiguous leads, however&#xD;
ST-elevation in V2-V3 ≥ 2,5 mm for males &lt; 40 years of age in ≥ 2 contiguous leads&#xD;
ST-elevation in V2-V3 ≥ 2,0 mm for males ≥ 40 years of age in ≥ 2 contiguous leads&#xD;
ST-elevation in V2-V3 ≥ 1,5 mm for females in ≥ 2 contiguous leads) or&#xD;
In V2-V3: Any q wave ≥ 0,02 seconds,&#xD;
In other leads: Q wave ≥ 0,03 seconds and &gt; 1 mm deep in ≥ 2 contiguous leads.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The occurence of postoperative hypoxemia during the first three postoperative days</measure>
    <time_frame>3 days</time_frame>
    <description>The occurence of postoperative hypoxemia during the first three postoperative days, defined as:&#xD;
the number of declines in saturation of 4 % (or more) lasting 20 seconds (or more) or&#xD;
number of desaturation episodes below 90 % or&#xD;
time (minutes( spent below 90 %,</description>
  </primary_outcome>
  <enrollment type="Anticipated">350</enrollment>
  <condition>Pulmonary Complication</condition>
  <condition>Cardiovascular Complication</condition>
  <condition>Postoperative Complications</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Major emergency abdominal surgery</intervention_name>
    <description>Major emergency gastrointestinal surgery performed within 72 hours of an acute admission or an acute reoperation.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients admitted to the department of Surgery, Zealand University Hospital, Denmark.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Surgery within 72 hours of an acute admission to the Department of Surgery or an acute&#xD;
             reoperation.&#xD;
&#xD;
          -  Major gastrointestinal surgery on the gastrointestinal tract.&#xD;
&#xD;
        This will include:&#xD;
&#xD;
          -  Open, laparoscopic, or laparoscopically-assisted procedures&#xD;
&#xD;
          -  Procedures involving the stomach, small or large bowel, or rectum for conditions such&#xD;
             as perforation, ischemia, abdominal abscess, bleeding or obstruction&#xD;
&#xD;
          -  Washout/evacuation of intra-peritoneal abscess (unless due to appendicitis or&#xD;
             cholecystitis - excluded, see below)&#xD;
&#xD;
          -  Washout/evacuation of intra-peritoneal hematoma&#xD;
&#xD;
          -  Bowel resection/repair due to incarcerated umbilical, inguinal and femoral hernias&#xD;
             (but not hernia repair without bowel resection/repair)&#xD;
&#xD;
          -  Bowel resection/repair due to obstructing/incarcerated incisional hernias provided the&#xD;
             presentation and findings were acute&#xD;
&#xD;
          -  Laparotomy/laparoscopy with inoperable pathology (e.g. peritoneal/hepatic metastases)&#xD;
&#xD;
          -  Laparoscopic/Open adhesiolysis&#xD;
&#xD;
          -  Return to theatre for repair of fascial dehiscence&#xD;
&#xD;
          -  Any reoperation/return to theatre meeting the criteria above is included&#xD;
&#xD;
        If multiple procedures (primary surgery or reoperation) are performed on different&#xD;
        anatomical sites within the abdominal/pelvic cavity, the patient would be included if the&#xD;
        major procedure is general surgical.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Not capable of giving informed consent after oral and written information&#xD;
&#xD;
          -  Previously included in the trial&#xD;
&#xD;
          -  Elective laparoscopy&#xD;
&#xD;
          -  Diagnostic laparotomy/laparoscopy where no subsequent procedure is performed (NB, if&#xD;
             no procedure is performed because of inoperable pathology, then include)&#xD;
&#xD;
          -  Appendectomy +/- drainage of localized collection unless the procedure is incidental&#xD;
             to a non-elective procedure on the GI tract&#xD;
&#xD;
          -  Cholecystectomy +/- drainage of localized collection unless the procedure is&#xD;
             incidental to a non-elective procedure on the GI tract (All surgery involving the&#xD;
             appendix or gallbladder, including any surgery relating to complications such as&#xD;
             abscess or bile leak is excluded)&#xD;
&#xD;
          -  Non-elective hernia repair without bowel resection.&#xD;
&#xD;
          -  Minor abdominal wound dehiscence unless this causes bowel complications requiring&#xD;
             resection&#xD;
&#xD;
          -  Ruptured ectopic pregnancy, or pelvic abscesses due to pelvic inflammatory disease&#xD;
&#xD;
          -  Laparotomy/laparoscopy for pathology caused by blunt or penetrating trauma&#xD;
&#xD;
          -  Laparotomy/laparoscopy for esophageal pathology&#xD;
&#xD;
          -  Laparotomy/laparoscopy for pathology of the spleen, renal tract, kidneys, liver, gall&#xD;
             bladder and biliary tree, pancreas or urinary tract&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ismail Gögenur, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Zealand University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jakob Burcharth, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Zealand University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ismail Gögenur, MD</last_name>
    <phone>+45 26336426</phone>
    <email>igo@regionsjaelland.dk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jakob Burcharth, MD</last_name>
    <email>jbur@regionsjaelland.dk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Surgery, Zealand University Hospital, Denmark.</name>
      <address>
        <city>Køge</city>
        <zip>4600</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ismail Gögenur, MD</last_name>
      <phone>+45 26336426</phone>
      <email>igo@regionsjaelland.dk</email>
    </contact>
    <contact_backup>
      <last_name>Jakob Burcharth, MD</last_name>
      <email>jbur@regionsjaelland.dk</email>
    </contact_backup>
    <investigator>
      <last_name>Adam Alexander Berkfors, Bsc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ellen Bjerrum, Bsc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jakob Burcharth, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sarah Busch, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ismail Gögenur, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>January 14, 2019</study_first_submitted>
  <study_first_submitted_qc>June 4, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 6, 2019</study_first_posted>
  <last_update_submitted>June 4, 2019</last_update_submitted>
  <last_update_submitted_qc>June 4, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 6, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Emergencies</mesh_term>
    <mesh_term>Postoperative Complications</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

